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Available online 28 April 2008Dilated cardiomyopathy (DCM), the most common form of cardiomyopathy, often leads to heart failure and
sudden death. While a substantial proportion of DCMs are inherited, mutations responsible for the majority of
DCMs remain unidentiﬁed. A genome-wide linkage study was performed to identify the locus responsible for
an autosomal recessive inherited form of juvenile DCM (JDCM) in Portuguese water dogs using 16 families
segregating the disease. Results link the JDCM locus to canine chromosome 8 with two-point and multipoint
lod scores of 10.8 and 14, respectively. The locusmaps to a 3.9-Mb region, with complete syntenic homology to
human chromosome 14, that contains no genes or loci known to be involved in the development of any type of
cardiomyopathy. This discovery of a DCM locuswith a previously unknown etiology will provide a newgene to
examine in human DCM patients and a model for testing therapeutic approaches for heart failure.







Genetic linkageCardiomyopathies are disorders of the heart muscle that are asso-
ciated with signiﬁcant morbidity and mortality due to heart failure.
Heart failure has been described as the emerging health epidemic of the
21st century [1–4]. The mortality rate due to cardiomyopathies in the
United States is greater than 10,000 deaths per year. Approximately 14%
of children affected with dilated cardiomyopathy (DCM) die at age 2 [5]
and themedian age of children listed for heart transplantation is 4 years
[2]. Cardiomyopathies are a heterogeneous groupof diseases. DCM is the
most common form of the primary cardiomyopathies and is character-
ized by ventricular dilation and impaired systolic function with normal
left ventricle wall thickness [6]. Inherited forms are common and may
account for up 35% of the cases [7–9], most of which showan autosomal
dominant mode of inheritance. Autosomal recessive inheritance
accounts for 24% of infantile forms of DCM [3,10]. There is evidence of
incomplete and age-dependent penetrance of DCM in humans, which,
together with the considerable mortality, have limited genetic studies.
Todate, 29 chromosomal loci that give rise toDCMare known inhumans
[9,11], with genes and mutations known for 27 of these. Nevertheless,
there are still many aspects of familial DCM that remain poorly
understood and it is anticipated that additional genes causative of
familial DCM will be discovered [7]. Identiﬁcation of these genes and
knowledge of their roles in cardiac function and in the pathogenesis of
DCM are major goals of ongoing research..
l rights reserved.Dogs provide advantages for the study of genetic disease due to the
many isolated populations that exist as individual dog breeds and the
high degree of medical scrutiny to which individual animals are subjec-
ted. Particularly, recessive and complex disorders are more likely to be
recognized as inheriteddiseases than inhumanpopulations, andgenetic
heterogeneity is likely to be reduced, at least within breeds. Large
sibships and the ability to perform speciﬁc matings are additional ad-
vantages and increase the capacity for naturally occurring dogmodels to
accelerate the discovery, characterization, and development of treat-
ment modalities for heart disease.
As in humans, DCM is the most prevalent form of cardiomyopathy
in dogs, with increased risk in large and giant breed dogs and with
advancing age [12]. Breed predisposition is apparent [13], and while
the notion of genetic predisposition is widely accepted, there are no
reports of speciﬁc gene mutations associated with canine DCM. We
have been investigating a juvenile form of canine DCM (JDCM) that is
unique in Portuguese water dog (PWD) families and is inherited as a
fully penetrant autosomal recessive trait [14–16].
JDCM in PWD was ﬁrst reported in a retrospective analysis of post-
mortem and biopsy case records of 12 related PWDs [14]. This was
followed by a prospective study of 124 PWD puppies, 10 of which were
affected [15]. The clinical course of JDCM ranges from sudden unex-
pected collapse and death with no preceding clinical signs (most com-
mon) to presence of clinical signs of depression and reduced appetite for
up to 5 days before collapse and fulminant congestive heart failure.
Affected dogs died between 2 and 32 weeks of age. Echocardiography
allows the earliest detection of JDCM, beginning 1–4 weeks before the
Fig. 1. Pedigree drawing of a PWD family segregating JDCM. No DNA was available for dogs represented by gray-shaded symbols. Black boxes or circles indicate affected male and
female dogs, respectively; unﬁlled and gray symbols represent unaffected animals, the diamond-shaped symbol represents a puppy born dead. All dogs were purebred PWDs with
the exception of dog 124, an unrelated mixed-breed dog, and her descendents. N, number of dogs of the indicated sex and phenotype, normal or affected.
518 P. Werner et al. / Genomics 91 (2008) 517–521onset of clinical signs. Extensive biochemical analysis has not revealed
any signiﬁcant differences between affected pups and normal age-mat-
ched controls [15]. Morphological and histological changes in the affec-
ted hearts have been described [14]. Based on the availability of DNA
from families with JDCM-affected pups and the simple mode of inhe-
ritance, we initiated a whole-genome scan to map the canine JDCM
locus.
Results
One of the more statistically powerful pedigrees included in this
study was produced in part in our breeding colony at the University of
Pennsylvania (Fig. 1). Three matings between the same carrier dogs, a
purebred PWDand amixed-breed dog (dogs 27 and 33, respectively, in
Fig.1), produced 7 affected puppies out of 24 offspring, consistent with
autosomal recessive inheritance of a single disease-causing allele.
A whole-genome scan was initiated using animals from 16 families
consistingof 119 dogs, ofwhich40were affectedwith JDCM.We initially
analyzed 120 markers, distributed throughout the whole genome, for
linkage to JDCM. Based on the linkage results, an additional 22 markers
were added to CFA3, CFA9, and CFA33 to evaluate regions that contained
markers with a lod score value greater than 1. None of these additional
markers generated lod scores greater than 1. Having excluded these
regions we continued to add an additional 29 polymorphic markers
throughout the genome to ﬁll in the largest gaps in the original linkageFig. 2. The multipoint lod score curve calculated for CFA8, with lod score indicated on the y a
the JDCM critical region deﬁned by haplotype analysis (see Fig. 3). Markers are named on tscan.Oneof thesemarkers, FH3316onCFA8, produced a lod score of 4.77
with a recombination fraction of 0.05.
We continued to analyze markers on CFA8 using single-nucleotide
polymorphisms (SNPs), simple sequence repeats, and short interspersed
nuclear element (SINE)markers (insertion/deletionpolymorphisms, see
Ref. [17]) that were developed based on publicly available information,
ﬁnding 12 markers that were polymorphic in the JDCM families. These
markers were spread throughout a 28-Mb region, with an average
intermarker distance of 1.6 Mb. Also, an additional 31 dogs, including 8
affected dogs, were added to the analysis. Two-point lod scores greater
than 3.5 were found for all markers in the region between 38.9 and
50.95 Mb on CFA8. A maximum lod score of 10.78 at a recombination
fraction of 0.035 was calculated for marker FH3316.
Multipoint linkage analysis with markers on CFA8 was performed
using GeneHunter 2.1 (Fig. 2). A maximum multipoint lod score of 14.0
was found for SNP marker rs24471950 at 42.4 Mb. We added ﬁve
additional SNP markers surrounding this marker to deﬁne the region of
interest further. Haplotype analysis deﬁned the JDCM critical region to
the interval from 40.5 to 44.4 Mb. The haplotypes at markers across the
region, for selected offspring of the large 24-member sibship shown in
Fig.1, are shown in Fig. 3. Thisﬁgure illustrates thatmarkers rs24465844
(at 40.5 Mb) and rs24485679 (at 44.4 Mb) differ in the two haplotypes
carrying themutant gene in dogs 27 and 33, and therefore they identify
ancestral recombinationevents surrounding the JDCMlocus thatdelimit
the JDCM critical interval.xis and the marker position on CFA8 indicated on the x axis. The shaded region indicates
he x axis.
Fig. 3. Pedigree and haplotypes for the informative animals from the single largest sibship used in this study, which is also part of Fig.1. No DNAwas available for dog 8011. Black boxes
or circles indicate affected male and female dogs, respectively; unﬁlled symbols represent unaffected animals. All founder dogs were purebred PWDs with the exception of dog 124,
an unrelated mixed-breed dog. The marker order is from the centromere. The haplotypes from the mutant-allele-bearing chromosomes are boxed. The JDCM critical interval is
indicated by gray shading.
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(HSA14q), with nearly perfect synteny, with the exception of a small
segment near the telomere in human that is displaced to the centromere
in dog [18]. This segment is outside of the JDCM critical region, which is
completely syntenic to a region on HSA14. Four genes and one locus
located on HSA14 have been identiﬁed as causing cardiomyopathies in
humans (see Fig. 4) but none of these loci are located within the iden-
tiﬁed interval on CFA8. Of these DCM loci, MYH6 [19] andMYH7 [20] are
located on CFA8 at 6.6 and 6.5Mb, respectively; PSEN1 [21] is at 49.5Mb
and TGFB3 is at 51.9 Mb [22]. The orthologous region of HSA14q12–q22
given for an arrhythmogenic right ventricular dysplasia 3 (ARVD3)
locus [23] is also located outside the JDCM region. Because of the initial
nearness of PSEN1 to the originally identiﬁed JDCM linked marker, and
becausemutations in the humanPSEN1genewere associatedwithDCM
[21], we sequenced and, consequently, excluded the canine PSEN1 gene
as a candidate gene for JDCM in the PWDs by failing to ﬁnd coding-
region or splice-site mutations. Two additional genes that were initially
chosen as candidate genes were HSPA2 (heat shock protein 2), due to
the involvement of HSPs in dilated cardiomyopathy [24], and ZBTB1
(zincﬁnger andBTBdomain-containingprotein1), due to ahighnumber
of canine ESTs expressed in heart. Sequencing of coding regions from
these potential candidate genes from affected dogs did not reveal any
sequence differences.
Discussion
Our data indicate thatwehave discovered a previously unrecognized
DCM locus onCFA8. Theavailabilityof ahigh-quality7.6× caninegenome
sequence [18] makes comparative mapping possible and indicates
complete synteny between the canine and the human genomes in the
JDCM critical regions. No genes known to be involved in the develop-
ment of any type of cardiomyopathy or ARVD are located within this
region in any species. One gene, PSEN1, located near but outside of this
region, was associated with DCM in humans, but was also excluded as
causative of JDCM by sequencing. Two additional candidate genes loca-
ted within the critical region were excluded as well. Genes with DCM-causing alleles can be found in multiple different pathways. DCM-cau-
singmutationshave been found inproteins of themyocyte cytoskeleton,
the dystrophin-associated complex, proteins involved in cytoarchitec-
ture, the nuclear envelope, the sarcomere, and the sarcoplasmic reticu-
lum, thus implicating calcium regulation. Perturbations in metabolic
processes can also cause DCM, including mitochondrial disease [see 25
for review]. There are 28 annotated genes remaining within the iden-
tiﬁed critical region for JDCM, some of which can be considered very
good candidate genes based on known function and tissue expression
patterns. Among the most intriguing candidate genes is Nesprin 2
(SYNE2), which codes for a giant protein that connects the nucleus and
theactin cytoskeletonandhas beenshown to interactwithACTC1 (actin,
α, cardiac muscle 1), mutations in which have been associated with
idiopathic DCM cardiomyopathy and familial hypertrophic cardiomyo-
pathy [26]. Sequence variations in SYNE1 and SYNE2 were found in
families segregating Emery–Dreifuss muscular dystrophy, a genetically
heterogeneous neuromuscular disorder. Some of the patients studied
suffered from severe DCM [27].
Because all known DCM genes have been ruled out by exclusion
from the JDCM interval, further studies will lead to the identiﬁcation
of a heretofore unknown DCM locus and will help unravel a pathway
that leads to a rapid decline in myocardial function resulting in heart
failure. Precedence for the molecular pathways involved in human
heart failure being elucidated by the study of animal models is well
established. Rodent DCMmodels have proven extremely applicable to
human inherited cardiac disease [see, for example, 28,29]. Given the
greater sequence homology between dog and human than between
human and rodents, the larger size and longer life span of dogs com-
pared to mice, and the physiological differences in heart function
between mouse and human, the discovery of the pathogenesis of this
JDCM in this dog model has signiﬁcant potential to yield new know-
ledge that will have an impact on human medicine and advance our
understanding of heart disease in general. Despite improvements in
medical treatment of heart failure in recent years, the clinical outcome
in human patients diagnosed with DCM has not changed. A better
understanding of the causes and pathogenesis of DCM, as well as new
Fig. 4. Idiograms of HSA14 and CFA8 showing the locations of the genes known to be
involved in cardiomyopathies or ARVD. The JDCM critical region, corresponding to
parts of HSA14q23–q24, is shaded.
520 P. Werner et al. / Genomics 91 (2008) 517–521therapies, are needed to achieve better care and outcome in children
and adults [9,10]. Once the mutation is identiﬁed this knowledge will
provide valuable new information about the causes and pathogenesis
of DCM. It will also provide a relevant, well-characterized model to
evaluate therapeutic approaches for dilated cardiomyopathy and for
other disease mechanisms that result in heart failure.
Materials and methods
Blood samples and clinical and pedigree data for affected and normal PWDs were
collected from client-owned animals and members of a family of dogs maintained at the
University of Pennsylvania (Fig. 1). Breeders and private owners also contributed samples
and data for members of PWD families segregating JDCM, with informed consent.
Diagnosis for privately owned animals was usually based on postmortem examination of
heart and lungs, combined with an increased heart weight/total body weight ratio, as
described in [14]. Some litters were evaluated weekly by echocardiography for signs of
failing heart function as described earlier [15], so that an antemortem diagnosis was
possible for somedogs. Affected animalswere euthanized before thedevelopmentof overt
congestive heart failure after deﬁnite and sustained deterioration of systolic function had
been observed over several serial examinations. Diagnoses of JDCM were conﬁrmed
postmortem. Kidney tissue or whole blood was collected for DNA isolation. All matings,
specimen collection, determination of clinical phenotype, and euthanasiawere performed
according to protocols approved by the Institutional Animal Care and Use Committee and
conforming to National Institutes of Health guidelines. Genomic DNA was isolated using
either a standard phenol/chloroform extraction protocol or, for small amounts of blood, a
PUREGENE DNA puriﬁcation kit (Gentra Systems,Minneapolis, MN, USA). PWDs surviving
past 8 months of age were considered normal.A total of 119 dogs from 16 families, including 40 affected dogs, were included in
this study. While some of the families shared common ancestors, large extended
families with more then 10 offspring were divided into single families to allow linkage
analysis with GeneHunter. The same pedigree structure was used for the analysis with
FastLink. Initially,120markerswere analyzedwith an additional 56markers added later
to increase marker density in speciﬁc regions. Most of the markers used were described
previously [30,31] and their ampliﬁcation followed either published conditions or
conditions previously described [32,33]. Unlabeled PCR products were analyzed on 6.4%
acrylamide gels, whereas ﬂuorescently labeled products were electrophoresed on an
ABI Prism 377 sequencer (Applied Biosystems, Foster City, CA, USA) or on an NEN Global
IR2 4200 sequencer system (Licor Biosciences, Lincoln, NE, USA). Allele sizes and
genotypes were determined using GeneScan analysis and Genotyper software (Applied
Biosystems) or SAGAGT (Licor Biosciences). Two-point linkage analysis was carried out
using the computer program FastLink 4.1P [34], and GeneHunter 2.1 [35] was used for
multipoint analysis using a model of fully penetrant autosomal recessive inheritance
and a disease allele frequency of 0.001. Marker allele frequencies were assumed equal
for the whole-genome linkage analysis. For the analysis on CFA8, the marker allele
frequencies were calculated by counting all alleles within the analyzed pedigree. The
differences in lod scores using the different frequencies were minor.
Once linkage was established, we used SNPs and bimorphic SINE [31] markers for
mapping in the region of interest on CFA8, spanning a region from 38.7 to 62.2 Mb, using
publicly available information [17,31]. SNP information for CFA8was downloaded from ftp.
ncbi.nlm.nih.gov/snp/organisms/dog_9615 and markers were chosen based on their
physical location and the alteration of a restriction enzyme cleavage site for analysis
purposes. To identify the modiﬁcation of a restriction enzyme recognition site, the list of
potential SNP markers was analyzed using the online tool WatCut (http://watcut.
uwaterloo.ca/watcut/watcut/template.php). PCR primers ﬂanking the SNP location were
chosenusing the computer programPrimerSelect from the Lasergene suite fromDNASTAR
(Madison, WI, USA). Information regarding primer sequences and restriction enzymes
used is available on request.
The positional candidate genes PSEN1 andHSPA2were sequenced from genomicDNA
from two or three affected dogs, whereas ZBTB1 (GenBank Accession Nos. EU5416225 and
EU541626) was sequenced from cDNA that was reverse transcribed frommRNA from the
left ventricular muscle tissue of two affected 12-week-old dogs that had been snap frozen
in LN2 immediately after euthanasia. mRNA was prepared using the Fast Track 2.0 mRNA
isolation kit and reverse transcribed into cDNAby the SuperScript III RTS First-Strand cDNA
Synthesis Kit, both from Invitrogen (Carlsbad, CA, USA). Resulting sequences were
compared to the published genome sequence or to sequence that was generated from a
normal mixed-breed dog (no PWD dog mix, no history of DCM).
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